
European Journal of Medicinal Chemistry p. 619 - 622 (1989)
Update date:2022-08-03
Topics:
Chapleo, Christopher B.
Doxey, John C.
Myers, Peter L.
Myers, Malcolm
Smith, Colin F. C.
Stillings, Michael R.
A preliminary communication reported on the pharmacology of the potent partial α2-agonist (2-(1,4-benzodioxan-6-ylamino)-2-imidazoline, a 1,4-dioxan derivative of clonidine.Its degree of agonism/antagonism depended upon the peripheral or central α2-adrenoreceptor system studied.It was of interest to discover whether a similar substitution of the 1,4-dioxan moiety in other standard α-adrenergic agents would similary produce high affinity compounds of complex pharmacological profile.The same substitution when introduced into guanfacine, fenmetazole and tolazoline resulted in unpredictable changes in profile with a reduction in α-affinity. - α2-adrenoreceptors/antagonism/agonism/clonidine derivatives/1,4-dioxan derivatives
View MoreBuffett (China) Holding Co.,Ltd
Contact:4006570891
Address:
website:https://www.finerchem.com
Contact:+86-531-88989536
Address:New Material Industrial Park, Jinan City, China
Shanghai Haoyuan Chemexpress Co., Ltd.
website:https://www.chemexpress.com/
Contact:86-21-58950125
Address:No.3 Building, No.1999, Zhangheng Road, ZhangjiangHighTech Park, Shanghai, P.R.China,201203
website:http://www.NEM.COM.CN
Contact:+86-393-4411771
Address:The west section of shengli Road,Puyang,Henan Province,China
Hefei TNJ chemical industry co.,ltd
website:https://www.tnjchem.com
Contact:+86-551-65418695
Address:B911 Xincheng Business Center, Qianshan Road, Hefei Anhui China
Doi:10.1021/jo00981a018
(1972)Doi:10.1039/c29710001496
(1971)Doi:10.1248/cpb.49.525
(2001)Doi:10.1007/BF00477394
()Doi:10.1021/acs.joc.5b01618
(2015)Doi:10.1016/S0960-894X(01)00776-4
(2002)